Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Richard Burack

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Biology|September 17, 2008
Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interactionTomás Vomastek, Marcin P Iwanicki, W Richard Burack, et al.
Leukemia Research|March 12, 2023
The role of splenectomy in management of splenic B-cell lymphomasWilliam J Archibald, Andrea M Baran, AnnaLynn M Williams, et al.
Leukemia Research|September 6, 2011
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature reviewMichael J Rauh, Fazlur Rahman, David Good, et al.
Blood Advances|January 4, 2018
Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironmentW Richard Burack, Janice M Spence, John P Spence, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2023
T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic FeaturesSiba El Hussein, Hong Fang, Fatima Zahra Jelloul, et al.
Cancers|April 26, 2025
Association Between B-Cell Marker Expression and <i>RUNX1</i> Lesions in Acute Myeloid Leukemia, Beyond <i>RUNX1</i>::<i>RUNX1T1</i> Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/MyeloidGiby V George, Malgorzata Kajstura, Audrey N Jajosky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsivenessShannon P Hilchey, James J Kobie, Mathew R Cochran, et al.
The Lancet. Haematology|February 4, 2018
R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre studyPaul M Barr, Hongli Li, W Richard Burack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulationMary A Markiewicz, Leonidas N Carayannopoulos, Olga V Naidenko, et al.
Ejhaem|September 2, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasmsSiba El Hussein, Mariko Yabe, Wei Wang, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Biology|September 17, 2008
Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interactionTomás Vomastek, Marcin P Iwanicki, W Richard Burack, et al.
Leukemia Research|March 12, 2023
The role of splenectomy in management of splenic B-cell lymphomasWilliam J Archibald, Andrea M Baran, AnnaLynn M Williams, et al.
Leukemia Research|September 6, 2011
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature reviewMichael J Rauh, Fazlur Rahman, David Good, et al.
Blood Advances|January 4, 2018
Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironmentW Richard Burack, Janice M Spence, John P Spence, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2023
T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic FeaturesSiba El Hussein, Hong Fang, Fatima Zahra Jelloul, et al.
Cancers|April 26, 2025
Association Between B-Cell Marker Expression and <i>RUNX1</i> Lesions in Acute Myeloid Leukemia, Beyond <i>RUNX1</i>::<i>RUNX1T1</i> Fusion: Diagnostic Pitfalls with Mixed-Phenotype Acute Leukemia-B/MyeloidGiby V George, Malgorzata Kajstura, Audrey N Jajosky, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsivenessShannon P Hilchey, James J Kobie, Mathew R Cochran, et al.
The Lancet. Haematology|February 4, 2018
R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre studyPaul M Barr, Hongli Li, W Richard Burack, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2005
Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulationMary A Markiewicz, Leonidas N Carayannopoulos, Olga V Naidenko, et al.
Ejhaem|September 2, 2022
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasmsSiba El Hussein, Mariko Yabe, Wei Wang, et al.
Pageof 6